A study led by researchers at the National Drug and Alcohol Research Centre (NDARC) outlines the profiles and circumstances of 43 deaths related to LSD or psilocybin (commonly known as magic mushrooms) in Australia between 2000 and 2023.
Workplaces have a substantial impact on workers' mental health and bear a large proportion of the social and economic burden associated with mental illness. This systematic review was undertaken to examine the current evidence base for workplace interventions addressing mental health problems in male-dominated industries.
This study examined the sexual health behaviour, alcohol and other drug use, and health service use among young Noongar people in the south-west of Western Australia.
This paper, published in The Lancet Psychiatry in September 2014, aimed to provide a broad picture of the psychosocial consequences of adolescent cannabis use.
This article discusses some considerations that can guide policy development within Australia regarding alcohol-exposed pregnancies and fetal alcohol spectrum disorder.
This publication summarises results from a study that set out to observe if, when, and how clinicians working in a publically funded alcohol/other drug (AOD) clinical service might utilise a computer-based psychological treatment program in their clinical practice.
This paper spotlights researchers' analyses of mortality in cohorts treated with oral naltrexone and methadone. They found large-scale use of oral naltrexone to treat opioid users may not have, as intended, saved lives.
Since the mid-1990s, there have been calls to make naloxone, a prescription-only medicine in many countries, available to heroin and other opioid users and their peers and family members to prevent